换一批
换一批The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates.
第一作者：
Natalie I,Mazur
第一单位：
Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, Netherlands; Department of Paediatrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, Netherlands.
作者：
Natalie I,Mazur [1]
;
Deborah,Higgins [2]
;
Marta C,Nunes [3]
;
José A,Melero [4]
;
Annefleur C,Langedijk [5]
;
Nicole,Horsley [6]
;
Ursula J,Buchholz [7]
;
Peter J,Openshaw [8]
;
Jason S,McLellan [9]
;
Janet A,Englund [10]
;
Asuncion,Mejias [11]
;
Ruth A,Karron [12]
;
Eric Af,Simões [13]
;
Ivana,Knezevic [14]
;
Octavio,Ramilo [15]
;
Pedro A,Piedra [16]
;
Helen Y,Chu [17]
;
Ann R,Falsey [18]
;
Harish,Nair [19]
;
Leyla,Kragten-Tabatabaie [20]
;
Anne,Greenough [21]
;
Eugenio,Baraldi [22]
;
Nikolaos G,Papadopoulos [23]
;
Johan,Vekemans [24]
;
Fernando P,Polack [25]
;
Mair,Powell [26]
;
Ashish,Satav [27]
;
Edward E,Walsh [28]
;
Renato T,Stein [29]
;
Barney S,Graham [30]
;
Louis J,Bont [31]
;
Respiratory Syncytial Virus Network (ReSViNET) Foundation
作者单位：
Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, Netherlands; Department of Paediatrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, Netherlands.
[1]
Center for Vaccine Innovation and Access, PATH, Seattle, WA, USA.
[2]
Medical Research Council: Respiratory and Meningeal Pathogens Research Unit and Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South Africa; Respiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, Netherlands.
[3]
Centro Nacional de Microbiología and CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III Majadahonda, Madrid, Spain.
[4]
Department of Paediatrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, Netherlands.
[5]
Department of Biology, University of Washington, Seattle, WA, USA.
[6]
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
[7]
National Heart and Lung Institute, Faculty of Medicine, Imperial College, London, UK.
[8]
Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA.
[9]
Department of Pediatrics, University of Washington, Seattle, WA, USA; Seattle Children's Research Institute, Seattle, WA, USA.
[10]
Respiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, Netherlands; Department of Pediatrics, Division of Infectious Diseases, Center for Vaccines and Immunity at Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA; Departamento de Farmacología y Pediatria, Facultad de Medicina, Universidad de Malaga, Malaga, Spain.
[11]
Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
[12]
Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA; Department of Epidemiology Center for Global Health, Colorado School of Public Health, Aurora, CO, USA.
[13]
Norms and Standards for Biologicals, Department of Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland.
[14]
Respiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, Netherlands; Department of Pediatrics, Division of Infectious Diseases, Center for Vaccines and Immunity at Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA.
[15]
Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA; Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, USA; Department of Molecular Virology and Microbiology, and Pediatrics, Baylor College of Medicine, Houston, TX, USA.
[16]
Respiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, Netherlands.
[17]
Respiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, Netherlands; Department of Medicine, University of Rochester and Rochester General Hospital, Rochester, NY, USA.
[18]
Respiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, Netherlands; Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
[19]
Respiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, Netherlands; Julius Clinical, Zeist, Netherlands.
[20]
Respiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, Netherlands; MRC-Asthma UK Centre in Allergic Mechanisms of Asthma, School of Life Course Sciences, King's College London, London, UK.
[21]
Respiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, Netherlands; Women's and Children's Health Department, University of Padova, Padova, Italy.
[22]
Respiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, Netherlands; Allergy Department, 2nd Paediatric Clinic, National Kapodistrian University of Athens, Athens, Greece; Division of Infection, Immunity & Respiratory Medicine, University of Manchester, Manchester, UK.
[23]
Initiative for Vaccine Research, World Health Organization, Geneva, Switzerland.
[24]
Respiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, Netherlands; Fundacion INFANT, Buenos Aires, Argentina.
[25]
Licensing Division, Medicines and Healthcare Products Regulatory Agency (MHRA), London, UK.
[26]
Mahatma Gandhi Tribal Hospital, Karmagram, Utavali, Tahsil, Dharni, India.
[27]
Department of Medicine, University of Rochester and Rochester General Hospital, Rochester, NY, USA.
[28]
Respiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, Netherlands; Pontificia Universidade Católica RGS (PUCRS), Porto Alegre, Brazil.
[29]
Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
[30]
Laboratory of Translational Immunology, University Medical Centre Utrecht, Utrecht, Netherlands; Department of Paediatrics, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, Netherlands; Respiratory Syncytial Virus Network (ReSViNET) Foundation, Zeist, Netherlands. Electronic address: l.bont@umcutrecht.nl.
[31]
主题词
抗体, 单克隆(Antibodies, Monoclonal);抗体, 病毒(Antibodies, Viral);人类(Humans);纳米粒子(Nanoparticles);呼吸道合胞体病毒感染(Respiratory Syncytial Virus Infections);呼吸道合胞病毒疫苗(Respiratory Syncytial Virus Vaccines);世界卫生组织(World Health Organization)
DOI
10.1016/S1473-3099(18)30292-5
PMID
29914800
发布时间
2023-02-01
- 浏览0
The Lancet. Infectious diseases
The Lancet. Infectious diseases
e295-e311页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
